Should frontline Hodgkin lymphoma therapy differ based on validated genetic, immunologic, or biochemical biomarkers?

Blood Immunology & Cellular Therapy · Elsevier

Аннотация

Publication date: December 2026 Source: Blood Immunology & Cellular Therapy, Volume 2, Issue 4 Author(s): Riad El Fakih, Mahmoud Aljurf, Abdullah Alamer, Abdulwahab A. Albabtain, Walid Rasheed, Mostafa F. Mohammed Saleh

Читать у издателя →

Похожие статьи